Home
Conditions
Lung Diseases, Obstructive

Clinical trial condition

Lung Diseases, Obstructive

Explore clinical trials studying Lung Diseases, Obstructive. Study availability and eligibility vary by location and protocol.

7,959 public trials 737 recruiting studies

Refine in advanced search Browse all conditions

Lung Diseases, Obstructive trial results

Completed

Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide

NCT01543919

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: Pfizer Investigational Site Birmingham, Alabama, United States

Pfizer Investigational Site Birmingham, Alabama, United States

Pfizer Investigational Site Birmingham, Alabama, United States

Pfizer Investigational Site Jasper, Alabama, United States

View all 132 locations

View Trial Details

Completed

Spiriva® 18µg Once Daily in Chinese COPD Patients of Different Disease Severities

NCT00621582

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: Not specified

View Trial Details

Completed

AZD2423 Safety and Tolerability Study in Patients With Moderate and Severe Chronic Obstructive Pulmonary Disease(COPD)

NCT01215279

Conditions: Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +8 more
Locations: Research Site Rousse, Bulgaria

Research Site Sofia, Bulgaria

Research Site Bratislava, Slovakia

Research Site Košice, Slovakia

View Trial Details

Completed

Combivent Respimat 1-year Safety Study in Patients With Chronic Obstructive Pulmonary Disease

NCT01019694

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: 1012.62.153 Boehringer Ingelheim Investigational Site Jasper, Alabama, United States

1012.62.145 Boehringer Ingelheim Investigational Site Mobile, Alabama, United States

1012.62.156 Boehringer Ingelheim Investigational Site Mesa, Arizona, United States

1012.62.135 Boehringer Ingelheim Investigational Site Berkeley, California, United States

View all 55 locations

View Trial Details

Completed

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

NCT01277523

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: 205.456.01004 Boehringer Ingelheim Investigational Site Stockton, California, United States

205.456.01008 Boehringer Ingelheim Investigational Site Normal, Illinois, United States

205.456.01003 Boehringer Ingelheim Investigational Site Baltimore, Maryland, United States

205.456.01007 Boehringer Ingelheim Investigational Site Columbia, Missouri, United States

View all 69 locations

View Trial Details

Completed

Ventilator Monitoring in Early Exacerbation Detection

NCT01644162

Conditions: Apnea, Chest Wall Disorder, Chronic Disease, +27 more
Locations: Royal Brompton Hospital London, United Kingdom

View Trial Details

Completed

Innovation in Pulmonary Rehabilitation

NCT00123422

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +7 more
Locations: Edward Hines, Jr. VA Hospital Hines, Illinois, United States

View Trial Details

Completed

Mechanisms of Vascular Damage in Patients With Chronic Obstructive Pulmonary Disease

NCT01020344

Conditions: Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
Locations: Pulmonary Division, University Hospital of Zurich Zurich, Switzerland

View Trial Details

Completed

Health Effects of Early-Life Exposure to Urban Pollutants in Minority Children

NCT00043498

Conditions: Asthma, Bronchial Diseases, Development, +7 more
Locations: Columbia University, 722 W 168th St, 12th Floor New York, United States

View Trial Details

Completed

Exercise and Neutrophil Function in COPD

NCT02124343

Conditions: Behavior, Chronic Disease, Chronic Obstructive Airway Disease, +9 more
Locations: Prince Philip Hospital Llanelli, Carmarthenshire, United Kingdom

View Trial Details

Lung Diseases, Obstructive

Lung Diseases, Obstructive trial results

Related conditions